Posted by Site Administrator on February 12, 2013
“This new finding sheds light on how the mutation causes these disorders, and it provides us with a marker that helps us track disease progression in patients with this disorder and potentially combat the disease,” says senior author Leonard Petrucelli, Ph.D., a molecular neuroscientist and director of the Department of Neuroscience at Mayo Clinic in Florida.
Categories: Research News, Technology, Treatments
| 
Tags: ALS community, ALS medical care, ALS research, ALS research funding, ALS treatments, amyotrophic lateral sclerosis, biomarker ALS, Bob Stehlin, C9ORF72 gene, C9RANT, Department of Neuroscience at Mayo Clinic Florida, DNA sequence ALS, frontotemporal dementia, Leonard Petrucelli, Lou Gehrig's disease, Mayo Clinic, motor neuron cells, Motor Neuron Disease, National Institutes of Health, neurodegenerative disorders, neuronal death and toxicity, PALS, RASCALS Foundation, Robert A. Stehlin Campaign for ALS, St.Louis RASCALS ALS Lou Gehrig's Disease amotrophic lateral sclerosis
| 
No comments
Posted by Site Administrator on November 29, 2012
Jean-Martin Charcot, born November 29, 1825 was a French neurologist and professor of anatomical pathology. He is known as “the founder of modern neurology” and is “associated with at least 15 medical eponyms“, including Charcot-Marie-Tooth disease and amyotrophic lateral sclerosis (motor neuron disease). One of Charcot’s greatest legacies as a clinician is his contribution to [...]
Categories: RASCALS Foundation News
| Tags: ALS, ALS research, amyotrophic lateral sclerosis, Charcot Disease, Jean-Martin Charcot, Lou Gehrig's disease, Motor Neuron Disease, RASCALS Foundation, Robert A. Stehlin Campaign for ALS, St.Louis RASCALS ALS Lou Gehrig's Disease amotrophic lateral sclerosis
| No comments
Posted by Site Administrator on October 23, 2012
A team led by scientists at The Scripps Research Institute has been awarded $2.1 million by the Department of Defense Congressionally Directed Medical Research Programs to study several compounds with the potential to greatly improve the quality of life for those with amyotrophic lateral sclerosis (ALS) or Lou Gehrig’s disease.
Categories: Research News, Technology, Treatments
| Tags: ALS, ALS community, ALS funding, ALS medical care, ALS research, amyotrophic lateral sclerosis, Bob Stehlin, c-Jun N-terminal kinase, Columbia University, Department of Defense, Lou Gehrig's disease, Motor Neuron Disease, motor neurone disease, PALS, Philip LoGrasso, RASCALS Foundation, Robert A. Stehlin Campaign for ALS, Scripps, St.Louis RASCALS ALS Lou Gehrig’s Disease amotrophic lateral sclerosis, The Scripps Research Institute
| No comments
Posted by Site Administrator on May 16, 2012
The ALS Therapy Development Institute (ALS TDI) announced today that it has entered into collaboration with Neurotune to investigate a potential treatment for ALS (aka Motor Neuron or Lou Gehrig’s disease).
Categories: Research News
| Tags: ALS, ALS community, ALS research, ALS TDI, ALS Therapy Development Institute, amyotrophic lateral sclerosis, Armin Mader, Lou Gehrig's disease, Motor Neuron Disease, neuromuscular junction, Neurotun, RASCALS Foundation, Robert A. Stehlin Campaign for ALS, St.Louis RASCALS ALS Lou Gehrig’s Disease amotrophic lateral sclerosis, Steve Perrin
| No comments
Posted by Site Administrator on April 27, 2012
“Using patient stem cells to model MND in a dish offers untold possibilities for how we study the cause of this terrible disease as well as accelerating drug discovery by providing a cost effective way to test many thousands of potential treatments.”
Categories: Research News, Treatments
| Tags: ALS, ALS community, ALS research, amyotrophic lateral sclerosis, Columbia University in New York, Dr Brian Dickie, Dr Siddharthan Chandran, induced pluripotent stem cells, iPSCs, King's College London, Lou Gehrig's disease, M337V, MND, Motor Neuron Disease, RASCALS Foundation, Robert A. Stehlin Campaign for ALS, St.Louis RASCALS ALS Lou Gehrig's Disease amotrophic lateral sclerosis, TDP-43 gene, University of Edinburgh
| No comments
